Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200902 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
NCT00200902 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 88 participants.
The verdict
NCT00200902, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.
Interventions
- OTHER Placebo
- DRUG Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)
- BEHAVIORAL Interpersonal Clinical Interaction (ICI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200902
The ClinicalTrials.gov registry entry for NCT00200902 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00200902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200902 about?
NCT00200902 is a clinical study titled "Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression". This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.
What is the current status of trial NCT00200902?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2005-08. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00200902?
The interventions under investigation include: Placebo (OTHER), Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro) (DRUG), Interpersonal Clinical Interaction (ICI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00200902?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.